Literature DB >> 7069236

Comparative efficacy of 10 antimicrobial agents in experimental infections with Bacteroides fragilis.

K Joiner, B Lowe, J Dzink, J G Bartlett.   

Abstract

The comparative efficacy of 10 antimicrobial agents against 15 strains of Bacteroides was examined in vivo using an experimental model of subcutaneous abscesses in mice. Results were evaluated by bacterial counts per lesion with the antimicrobial agents administered beginning 1 hr after challenge. Six drugs reduced counts (mean +/- SEM log decrease) significantly compared with values in untreated control animals: metronidazole, 6.7 +/- 0.6; clindamycin, 5.0 +/- 0.6; moxalactam, 3.8 +/- 0.5; cefoxitin, 3.5 +/- 0.5; chloramphenicol, 1.6 +/- 0.5; and carbenicillin, 1.0 +/- 0.3. Antimicrobial agents that had no significant effect compared with values in untreated control animals were cephalothin, cefoperazone, ceforanide, and rosaramicin. Evaluation of several parameters based on in vitro activity and pharmacokinetic properties at the infected site indicated that the time during which the level of antimicrobial agent exceeded the minimal inhibitory concentration correlated best with in vivo antibacterial activity. A delay in the time that treatment was initiated resulted in a marked reduction in in vivo activity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7069236     DOI: 10.1093/infdis/145.4.561

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

1.  In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model.

Authors:  L E Stearne; I C Gyssens; W H Goessens; J W Mouton; W J Oyen; J W van der Meer; H A Verbrugh
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

Review 2.  Encapsulated anaerobic bacteria in synergistic infections.

Authors:  I Brook
Journal:  Microbiol Rev       Date:  1986-12

3.  Comparison of kill-kinetic studies with agar and broth microdilution methods for determination of antimicrobial activity of selected agents against members of the Bacteroides fragilis group.

Authors:  C W Stratton; L S Weeks; K E Aldridge
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

4.  Effect of a single percutaneous abscess drainage puncture and imipenem therapy, alone or in combination, in treatment of mixed-infection abscesses in mice.

Authors:  Lorna E T Stearne; Steven L Buijk; Johan W Mouton; Inge C Gyssens
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

5.  Use of lymphokines in treatment of experimental intra-abdominal abscess caused by Bacteroides fragilis.

Authors:  S V Gollapudi; A Gupta; H Thadepalli; A Perez
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

6.  Successful antimicrobial therapy of hepatic, intra-abdominal and intrapelvic abscesses.

Authors:  E D Ralph
Journal:  Can Med Assoc J       Date:  1984-09-15       Impact factor: 8.262

7.  Correlation between in vitro and in vivo activity of antimicrobial agents against gram-negative bacilli in a murine infection model.

Authors:  B Fantin; J Leggett; S Ebert; W A Craig
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

Review 8.  Intra-abdominal infections in children. Pathogenesis, diagnosis and management.

Authors:  I Brook
Journal:  Drugs       Date:  1993-07       Impact factor: 9.546

9.  Efficacy of ofloxacin (HOE 280) in a model of subcutaneous abscess: penetration and prevention of abscess formation.

Authors:  M C García Iglesias; E J Perea
Journal:  Infection       Date:  1986       Impact factor: 3.553

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.